Skip to main content
Equibles
DSGN logo

DSGN · Design Therapeutics, Inc. · Proposed Sales

Track DSGN — free

Use DSGN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research DSGN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$10.52 +0.31 (+3.04%) Play latest call Q3 2025 earnings call transcript
Russell 2000 member Rebalance outlook locked
Market Cap
$653.81M
Shares
64.04M
Volume · Nov 9 70.68K Avg daily vol (3M) 581.33K

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2025-11-18 Logos Global Master Fund LP 120,000
2025-11-14 Logos Global Master Fund LP 620,000
2025-11-07 Logos Global Master Fund LP 415,000
2025-08-13 Logos Global Master Fund LP 345,000
2025-08-13 Logos Opportunities Fund II LP 217,627
2024-08-09 Logos SPV 1 LP 814,874
Showing 1–6 of 6 filings
Key facts CIK 1807120 CUSIP 25056L103 13F (30d) 53 filings 41 filers Visit website Investor relations